(Alliance News) - Daiichi Sankyo Co Ltd on Thursday said the European Medicines Agency has validated the application for Enhertu to treat patients with a range of tumours. Read More
(Alliance News) - European stocks opened largely in the green on Thursday, as investors gear up for a US inflation reading and a European Central Bank decision. Read More
(Alliance News) – AstraZeneca PLC said on Sunday that its Tagrisso lung cancer treatment plus chemotherapy delivered the longest survival benefits recorded in phase three trials. Read More
(Alliance News) - London's FTSE 100 was set to open slightly higher on Monday, following a soft UK house price reading and ahead of mortgage approvals data later in the day. Read More
(Alliance News) - AstraZeneca PLC on Saturday celebrated phase 3 trial results on baxdrostat, an aldosterone synthase inhibitor that targets one of the hormones driving elevated blood pressure and increased cardiovascular and renal risk. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The FTSE 100 made steady progress on Wednesday, pushing back towards record highs, as hopes grew that the US Federal Reserve will lower interest rates in the coming months. Read More
(Alliance News) - Rolls-Royce Holding PLC's plan to power artificial intelligence with its small nuclear reactors could make it the UK's most valuable company, its chief executive told the BBC. Read More
(Alliance News) - London's FTSE 100 outperformed on Monday, sitting solidly higher in afternoon dealings, though stocks in mainland Europe faded. Read More
(Alliance News) - London's FTSE was on the decline on Thursday afternoon, while the pound moved above the USD1.34 mark, after the Bank of England cut rates in a decision that needed a second vote. Read More
(Alliance News) - The FTSE 100 sank on Friday after US President Donald Trump announced tariffs on dozens of trading partners, and weak US jobs data fuelled concerns as to the strength of the US economy. Read More
(Alliance News) - The FTSE 100 struggled for direction on Wednesday, despite progress elsewhere, as investors digested another earnings deluge and looked ahead to the US rate call and earnings from technology titans Meta Platforms and Microsoft. Read More
(Alliance News) - The FTSE 100 made strong progress on Tuesday boosted by results from AstraZeneca and Barclays, but it was gloomy day for investors in Novo Nordisk. Read More
(Alliance News) - The FTSE 100 was higher at midday on Tuesday, boosted by well-received earnings, while peers in Europe were back on the up after struggling at the start of the week as Monday's initial lift from a US-EU trade agreement proved short-lived. Read More
(Alliance News) - Stock prices in London opened mixed on Tuesday, as an earnings boost at AstraZeneca was well received by investors and supported the blue-cap index. Read More